Carotid Intima Media Thickness, Inflammatory Markers, and Endothelial Activation Markers in HIV Patients with Lipoatrophy Increased at 48 Weeks Regardless of Use of Rosiglitazone or Placebo

Rosiglitazone may be useful for the treatment of antiretroviral therapy-associated lipoatrophy, but an association with cardiovascular disease (CVD) has been questioned in diabetics. We evaluated rosiglitazone's effect on surrogate markers of CVD in HIV-infected individuals with lipoatrophy. HI...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Tungsiripat, Marisa, El-Bejjani, Dalia, Rizk, Nesrine, Dogra, Vikram, O'Riordan, Mary Ann, Ross, Allison C., Hileman, Corrilynn, Storer, Norma, Harrill, Danielle, McComsey, Grace A.
Médium: Artigo
Jazyk:Inglês
Vydáno: Mary Ann Liebert, Inc. 2011
Témata:
Preclinical Studies/Drug Development
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3064528/
https://ncbi.nlm.nih.gov/pubmed/20969457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2010.0187
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky